Michael Kelliher
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Michael Kelliher currently works at Capricor Therapeutics, Inc., as Independent Director from 2023 and Ardelyx, Inc., as Chief Business Officer from 2025.
Mr. Kelliher also formerly worked at Horizon Therapeutics Ltd. (Ireland), as Group Vice President-Merger & Acquisition.
Mr. Kelliher received his undergraduate degree from University College Cork.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARDELYX, INC. 0,14 % | 21/05/2026 | 357 418 ( 0,14 % ) | 2 M $ | 31/05/2026 |
| 28/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | 25/03/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
University College Cork
University College Cork Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national